Use this link to cite:
https://hdl.handle.net/2183/47041 Central hypothyroidism and cardiovascular disease: a Spanish cohort observational study
Loading...
Identifiers
Publication date
Authors
Guerrero-Pérez, Fernando
Iglesias, Pedro
Paja Fano, Miguel
Moure Rodríguez, María Dolores
Biagetti, Betina
Novoa-Testa, Iria
García-Centeno, Rogelio
González-Fernández, Laura
Araújo-Castro, Marta
Advisors
Other responsabilities
Journal Title
Bibliographic citation
Guerrero-Pérez F, Iglesias P, Paja Fano M, Moure Rodríguez MD, Biagetti B, Cordido F, Novoa-Testa I, García-Centeno R, González Fernández L, Araujo-Castro M, Villar-Taibo R, García L, Fernández-Rodríguez E, Capristán-Díaz V, Simó-Servat A, Aulinas A, Asla Q, Tenorio-Jiménez C, Díez JJ; Neuroendocrinology Task Force of Spanish Society of Endocrinology and Nutrition. Central hypothyroidism and cardiovascular disease: a Spanish cohort observational study. Hormones (Athens). 2025 Aug 18. Epub ahead of print.
Type of academic work
Academic degree
Abstract
[Abstract] Purpose: Little is known about cardiovascular (CV) risk in patients with central hypothyroidism. We aimed to describe the prevalence and incidence of cardiovascular risk factors (CVRFs), cardiovascular diseases (CVDs), and mortality in adults with central hypothyroidism.
Methods and patients: This multicenter, retrospective, observational study included patients with central hypothyroidism treated at 14 tertiary hospitals in Spain.
Results: A total of 637 patients were analyzed, 339 (53.2%) of whom were male, with a median age of 54 [IQR: 40-67] years. Among them, 582 (91.4%) had combined central hypothyroidism and 55 (8.6%) isolated central hypothyroidism. At baseline, 218 (34.2%) had dyslipidemia, 200 (31.4%) hypertension, and 84 (13.2%) diabetes. In addition, 21 (3.3%) had a history of myocardial infarction, eight (1.3%) chronic coronary syndrome, nine (1.4%) heart failure, and 20 (3.1%) cerebrovascular disease. Median follow-up was 7.0 [3.3-11.8] years, and seven (1.1%) patients recovered from other hormone deficiencies. At the last visit, 575 (90.3%) had combined central hypothyroidism and 62 (9.7%) isolated central hypothyroidism. From the time of diagnosis to the last visit, incident CVRFs included dyslipidemia in 182 (43.4%), hypertension in 104 (23.8%), and diabetes in 67 (12.1%) patients. Incident CVDs included 16 (2.6%) myocardial infarctions, 11 (1.7%) chronic coronary syndromes, 17 (2.7%) heart failures, and 33 (5.3%) cerebrovascular diseases. Incident CVRFs, most CVDs, and mortality were similar between patients with combined and isolated central hypothyroidism. During follow-up, 46 (7.2%) patients died, with causes including infections (32.6%), CVDs (21.7%), and malignancies (21.7%).
Conclusions: Central hypothyroidism is associated with a high prevalence of CVRFs. The incidence of CVRFs, most CVDs, and mortality were similar in patients with isolated and combined central hypothyroidism.
Description
Editor version
Rights
This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at Springer Nature Link.






